You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 16, 2025

Drug Price Trends for NECON


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NECON

Average Pharmacy Cost for NECON

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NECON 0.5-35-28 TABLET 51862-0892-03 0.45936 EACH 2025-01-22
NECON 0.5-35-28 TABLET 75907-0085-32 0.45936 EACH 2025-01-22
NECON 0.5-35-28 TABLET 75907-0085-28 0.45936 EACH 2025-01-22
NECON 0.5-35-28 TABLET 51862-0892-01 0.45936 EACH 2025-01-22
NECON 0.5-35-28 TABLET 51862-0892-03 0.46498 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for NECON

Introduction

NECON, a combination oral contraceptive containing norethindrone and ethinyl estradiol, is a widely used medication for preventing pregnancy. To understand the market dynamics and price projections for NECON, it is essential to analyze various factors including market trends, regulatory changes, and broader pharmaceutical industry outlook.

Market Context for Contraceptives

The market for contraceptives, including combination oral contraceptives like NECON, is influenced by several factors such as demographic changes, healthcare policies, and the availability of generic alternatives.

Demographic Factors

The demand for contraceptives is driven by the reproductive health needs of the population. For example, the market basket analysis for drugs commonly taken by women aged 25-39, which includes many on-patent birth control pills, shows significant variations in pricing and usage[1].

Healthcare Policies and Regulations

Recent healthcare policies, such as those outlined in the Inflation Reduction Act, have significant implications for prescription drug spending. These policies aim to reduce out-of-pocket spending and aggregate drug costs through mechanisms like drug price negotiations and inflation rebates. While these policies are more broadly focused, they can impact the pricing and accessibility of all prescription drugs, including NECON[5].

Pricing Trends in the Pharmaceutical Market

Pricing trends in the pharmaceutical market are complex and influenced by multiple factors.

U.S. vs. Canadian Prices

Historical data shows that prices for prescription drugs, including contraceptives, can vary significantly between the U.S. and Canada. For instance, market baskets of drugs commonly taken by women aged 25-39 have shown Canadian prices to be 54% lower than U.S. prices for those without third-party coverage[1].

Impact of Generic and Branded Drugs

The mix of brand and generic drugs in market baskets significantly affects pricing. Generic drugs, which are often cheaper, can reduce the overall cost of a market basket. However, the market basket for young women, which includes many on-patent birth control pills like NECON, tends to have a lower generic rate, contributing to higher costs[1].

Future Price Projections

Overall Pharmaceutical Spending

The overall pharmaceutical market is expected to see significant growth. For 2024, prescription drug spending is projected to rise by 10.0% to 12.0%, driven by factors such as increased utilization, new drug approvals, and price increases[2].

Specific to Contraceptives

While specific projections for NECON are not available, the broader contraceptive market is likely to be influenced by these general trends. The increasing demand for reproductive health services and the potential for new policy changes could impact pricing.

Regulatory and Policy Changes

The Inflation Reduction Act's provisions, which include drug price negotiations and inflation rebates, are expected to reduce aggregate drug costs and out-of-pocket spending. This could lead to more stable or even reduced prices for prescription drugs, including contraceptives like NECON, over the next decade[5].

Market Drivers and Challenges

Market Drivers

  • Increasing Demand: The ongoing need for reproductive health services drives the demand for contraceptives.
  • New Product Launches: Although not specific to NECON, new drug launches in the broader pharmaceutical market can influence pricing and market dynamics.
  • Healthcare Policies: Policies aimed at reducing drug costs can make prescription medications more affordable, potentially increasing demand.

Market Challenges

  • Generic Competition: The availability of generic alternatives can reduce the market share and pricing power of branded drugs like NECON.
  • Regulatory Changes: Changes in healthcare policies and regulations can impact the pricing and accessibility of prescription drugs.

Competitive Landscape

The contraceptive market is competitive, with several brands and generic alternatives available. NECON competes with other combination oral contraceptives, and its market position can be influenced by the availability of these alternatives and any changes in their pricing strategies.

Key Takeaways

  • Pricing Variability: Prices for NECON and similar contraceptives can vary significantly between the U.S. and Canada, and are influenced by the mix of brand and generic drugs.
  • Regulatory Impact: Recent healthcare policies aimed at reducing drug costs could stabilize or reduce prices for prescription drugs, including NECON.
  • Market Growth: The overall pharmaceutical market is expected to grow, driven by increased utilization, new drug approvals, and other factors.
  • Competitive Dynamics: The market for contraceptives is competitive, with generic alternatives playing a significant role in pricing and market share.

FAQs

Q: How do U.S. and Canadian prices for NECON compare?

A: Historical data shows that Canadian prices for prescription drugs, including contraceptives like NECON, can be significantly lower than U.S. prices, with differences ranging up to 54% for certain market baskets[1].

Q: What impact do healthcare policies have on the pricing of NECON?

A: Policies like the Inflation Reduction Act, which include drug price negotiations and inflation rebates, are expected to reduce aggregate drug costs and out-of-pocket spending, potentially making NECON and other prescription drugs more affordable[5].

Q: How does the mix of brand and generic drugs affect the pricing of NECON?

A: The mix of brand and generic drugs in market baskets significantly affects pricing. Since the market basket for young women includes many on-patent birth control pills like NECON, the generic rate is lower, contributing to higher costs[1].

Q: What are the projected trends in pharmaceutical spending for 2024?

A: Prescription drug spending is projected to rise by 10.0% to 12.0% in 2024, driven by increased utilization, new drug approvals, and price increases[2].

Q: How does the competitive landscape affect NECON’s market position?

A: The contraceptive market is competitive, with several brands and generic alternatives available. NECON competes with other combination oral contraceptives, and its market position can be influenced by the availability and pricing strategies of these alternatives.

Sources

  1. ASPE Report: Picking market baskets of drugs - ASPE[1]
  2. National trends in prescription drug expenditures: PubMed[2]
  3. Oncology Drugs Market Size, Share & Growth: Fortune Business Insights[3]
  4. Necon (Norethindrone and Ethinyl Estradiol Tablets): RxList[4]
  5. Recent and forecasted trends in prescription drug spending: Health System Tracker[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.